PTGX

Protagonist Therapeutics, Inc.

A biotechnology company that designs oral and injectable peptide drugs for chronic conditions like psoriasis, blood disorders, and obesity. Founded in 2006 on peptide technology from the University of Pennsylvania, it was incubated in Australia before moving to California. Its name was chosen to suggest a central role in peptide medicine, and its psoriasis pill Icotyde is licensed to Johnson & Johnson.

CUSIP: 74366E1022 holders

Ownership Activity Financials Filings

PTGX

PTGX

Results of Operations and Financial Condition

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Regulation FD Disclosure

Results of Operations and Financial Condition

Results of Operations and Financial Condition

Submission of Matters to a Vote of Security Holders